Bart Van Waeyenberge

EMEA Head of CAR T Operations Johnson & Johnson and Board Member Janssen Pharmaceutica N.V.

Beerse, Flemish Region, Belgium

About

Strategy, People, Financials, Change Management, Lean Culture, Operational and General Management in local and global functions. Exposed to European, US and Asia-pac cultures. API, sterile/non-sterile fill finish including vaccines Strategie, Mensen, Financiën, Verandering, Lean Cultuur, Operationeel & Algemeen management. Ervaring met e-Europese, US en Asia-pac culturen. API, sterile/non-sterile fill finish including vaccines

Experience

  • Johnson & Johnson Innovative Medicine (30 yrs 11 mos)
    • Head of EMEA CAR T Operations
      Sep 2022 - Present · 3 yrs 11 mos

      End to End accountability for the Immunotherapy CAR T Operations within Europe. Immunotherapy is an innovative approach within oncology.

    • Board Member
      Apr 2014 - Present · 12 yrs 4 mos

    • Global Strategy & Transformation Leader
      Oct 2021 - Sep 2022 · 1 yr

      Accountable to shape and implement global transformation programs within Janssen

  • Board Member at GS1
    Sep 2018 - Present · 7 yrs 11 mos

  • Board Member at ETION
    Sep 2009 - Present · 16 yrs 11 mos

    Strategic Direction Setting

  • Maintenance Manager at Monsanto Company
    Jul 1991 - Sep 1995 · 4 yrs 3 mos

    Process & Maintenance Lead